ovarian cancer

23andMe’s New BRCA1/BRCA2 Report

April 11, 2018
23andMe's new BRCA1/BRCA2 (Selected Variants) report looks at three variants in the BRCA1 and BRCA2 genes associated with an increased risk of breast, ovarian and prostate cancer. These three variants are most common in people of Ashkenazi Jewish descent, but having one of these variants carries serious risk no matter your ancestry.
Read More

A Major Milestone in Consumer Health Empowerment

March 06, 2018
23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 report. The report covers three variants in the BRCA1 and BRCA2 genes associated with increased risk for breast, ovarian, and prostate cancer.
Read More

New genetic variants found to influence puberty timing and cancer risk

April 27, 2017
In the largest study of its kind researchers at the University of Cambridge have identified more than 380 genetic variants associated with the timing of puberty in men and women. The...
Read More

SNPwatch: Researchers Link Common Genetic Variations To Those Changes A Woman’s Body Goes Through

May 18, 2009
SNPwatch gives you the latest news about research linking various traits and conditions to individual genetic variations. These studies are exciting because they offer a glimpse into how genetics may...
Read More

The Story of Henrietta Lacks: A Lesson in Biology and Ethics

January 30, 2009
Editor’s note: We posted this a couple of years ago, but in light on the historic agreement between the family of Henrietta Lacks and National Institutes of Health, we thought...
Read More